Spren Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2017

Location

Asheville NC US

Primary Industry

Medical Devices & Equipment

About

Based in North Carolina, US, and founded in 2017 by Jason Moore (CEO), Elite HRV, Inc. doing business as Spren operates as a medical device company that offers a camera-enabled, digital biomarker platform that connects an app to the human body. In October 2022, Spren raised USD 11.3 million in seed funding led by DRIVE by DraftKings, with participation from Boston Seed Capital, Karlani Capital, and Permit Ventures. Spren's evidence-based machine learning algorithms deliver actionable biomarker insights such as HRV (Heart rate variability), body composition, stress, recovery, progress tracking, and more via an easy-to-integrate SDK (Software Development Kit) and API. The company plans to use the October 2022 funding to accelerate the expansion of its enterprise biomarker platform.

Current Investors

Boston Seed Capital, Karlani Capital, Amasia

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Monitoring Equipment, Application Integration Software

Website

www.spren.com

Verticals

Cloud Computing, HealthTech, Mobile Apps

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Employee Data

Want to see the Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.